Janani Rangaswami
@RangaswJ
Followers
1K
Following
27K
Media
73
Statuses
2K
Nephrologist, Professor of Medicine, GWU, Immediate Past Chair@kidneyinCVD @AHA, #CKMH@AHA, Views =My own
George Washington University
Joined June 2018
CKM Syndrome: The next frontier in integrated care starts here. Join us for a half-day CKM symposia at Scientific Sessions 2025.
0
8
38
.@KidneyInCVD friends! Attending @AHAMeetings Scientific Sessions #AHA25 in New Orleans? Learn more about Cardiovascular-Kidney-Metabolic syndrome by attending this certificate program!!👇👇👇👇Info about 💰💰 here: https://t.co/uq1R1318ip
@RangaswJ @ChiadiNdumele @CouncilonHTN
1
4
10
Are you attending the #AHA25 Scientific Sessions in New Orleans and you are interested in cardiovascular-kidney-metabolic syndrome #CKM? Consider joining this certificate program! You will need to register for it! https://t.co/URa0KStifv
@KidneyInCVD @RangaswJ @ChiadiNdumele
professional.heart.org
0
5
16
Many congrats @rkramann ! Very richly deserved @AHAScience @KidneyInCVD @ASNKidney @Carmendemigue12 @BhallaResearch @staruschenko @asouth_neph
Honored to receive the Donald W. Seldin Award from @ASNKidney. This is really a tribute to our incredible team and brilliant trainees. Grateful and feeling young again
1
1
9
1/ Mark your calendar! Here are all the opportunities to learn more about cardiovascular-kidney-metabolic syndrome at Scientific Sessions. #AHA25 #CKMsyndrome
@ChiadiNdumele @HeartDocSadiya @gcfmd @joshuajosephmd @PowellWileyLab @RangaswJ @dramitkhera
1
8
20
@ChiadiNdumele @HeartDocSadiya @gcfmd @joshuajosephmd @PowellWileyLab @RangaswJ @dramitkhera 2/ Mark your calendar at #AHA25 for these PREVENT calculator learning opportunities.
0
7
12
The new CKM staging model highlights the progressive overlap of cardiovascular, kidney, and metabolic disease risk. From Stage 0 (primordial prevention) to Stage 4 (clinical CVD). A new framework to guide prevention, risk stratification, and treatment. #CardioRenalMetabolic #CKM
2
11
39
Kidney Dysfunction in Heart Failure: Core Curriculum 2025 - American Journal of Kidney Diseases
ajkd.org
The pathophysiology of heart failure (HF) with kidney dysfunction is represented by several maladaptive bidirectional pathways wherein acute or chronic dysfunction of one organ drives acute or...
0
24
56
Rapid and Simultaneous Initiation of Guideline-Directed Kidney Therapies in Patients with CKD and Type 2 Diabetes (T2D) ca. 2025 from @asnpublications @JavedButler1 @RangaswJ
#Nephpearls 👉 https://t.co/yYpq5hWgZD
1
58
152
Now out @JAMA_current simultaneous with @AHAScience #Hypertension25 work led by Dr. Alexa Freedman @NUPrevMed on CVD mortality risk identified by BP measured as early as age 7 - #Prevention must start earlier @NUFeinbergMed @NMCardioVasc
https://t.co/ogZVBYt7YE
jamanetwork.com
This cohort study examines the association of elevated blood pressure at age 7 years with cardiovascular disease mortality later in life.
3
15
55
Ultraprocessed Foods and Their Association With Cardiometabolic Health: Evidence, Gaps, and Opportunities: A Science Advisory From the American Heart Association | Circulation
ahajournals.org
Ultraprocessed foods and beverages (UPFs) pose a growing public health challenge. Commonly defined by the Nova system, UPFs are industrially processed products made with additives or ingredients not...
0
3
5
Editorial by @gchertow: Embracing the Generational Opportunity to Improve the Care of Kidney Disease https://t.co/kfws4tNjuD (FREE) @StanfordNeph
1
5
13
In this RCT of 13299 pts w T2DM, CVD, overweight/obesity, #tirzepetide was non-inferior to #dulaglutide for primary endpoint of CV death, MI, or stroke Threshold for superiority not met In exploratory analyses, there were improvements in metabolic end points. #SurpassCVOT
❗️Tirzepatide meets primary and secondary outcomes in its CVOT (SURPASS-CVOT)❗️ 🔹A first for CVOTs - comparing to dulaglutide (established benefit) 🔸Statistical analysis allows for comparison to putative placebo 🔹1ry outcome HR 0.92 p=0.086 🔸2ndry outcome HR 0.84 0=0.002
2
4
20
New episode this week! We discuss pragmatic trial infrastructure in Denmark, implementation science in nephrology and how new approaches to recruitment can improve access, equity and representation in trials #kidneycompass
New episode of #KidneyCompass coming soon! Follow @HCPLiveNews for the latest releases of this podcast and many others!
2
10
18
SGLT2i in CKD: impact beyond kidneys 🔻 15% all-cause hospitalizations ✅ Consistent across eGFR, UACR & diabetes 🏥 ~36 fewer hospitalizations per 1000 pt-years Large absolute gains for patients & health systems. Meta-analysis in @asnpublications: 🔗 https://t.co/NU7EpDVheA
1
43
123
Interconnected pathways and emerging therapies in chronic kidney disease and heart failure: A comprehensive review Early diagnosis and intervention are important to slow CKD progression and reduce HF events. Shared therapeutic targets for CKD and HF include the renin–angiotensin
1
4
18
.@KidneyInCVD friends! Come gather in Baltimore for #Hypertension25! Don't miss out on the opportunity to gain cross-disciplinary connections and learn more about empowering hearts and uniting against #Hypertension this September Register: https://t.co/iC0PYuy0Lq
#AHAScience
1
8
15
This Core Curriculum explores commonly implicated pathophysiological mechanisms in kidney dysfunction in heart failure and discuss principles behind effective decongestion and assessment of adequacy of natriuresis: https://t.co/H4w5DvcEBh (FREE) @KevinBryanLo @UVoverP @RangaswJ
0
34
79
Absolutely delighted to host Prof @RangaswJ in Sydney this week - great talks and discussions with our faculty, nephrology trainees, and overseas visiting fellows from across the region - a few more pics from me! @georgeinstitute @NthSydHealth @north_fndn
It was wonderful to visit @georgeinstitute and Royal North Shore hospital and meet with @brendonneuen and colleagues ! Enjoyed our discussions on #Cardiorenal Syndrome, decongestion and #GDMT, and beyond !
0
1
20
It was wonderful to visit @georgeinstitute and Royal North Shore hospital and meet with @brendonneuen and colleagues ! Enjoyed our discussions on #Cardiorenal Syndrome, decongestion and #GDMT, and beyond !
0
1
20